Monopar Therapeutics
MNPR
#8223
Rank
โ‚ฌ0.16 B
Marketcap
27,37ย โ‚ฌ
Share price
-13.27%
Change (1 day)
829.68%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2023 (TTM): -0,73ย โ‚ฌ

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is -0,70ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,76ย โ‚ฌ a decrease over its 2021 EPS that were of -0,68ย โ‚ฌ.

EPS history for Monopar Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,73ย โ‚ฌ-3.69%
2022-0,76ย โ‚ฌ12.16%
2021-0,68ย โ‚ฌ27.59%
2020-0,53ย โ‚ฌ43.71%
2019-0,37ย โ‚ฌ33.52%
2018-0,28ย โ‚ฌ-80.97%
2017-1,45ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,99ย โ‚ฌ 183.12%๐Ÿ‡บ๐Ÿ‡ธ USA